← All peptides
Healing & Recovery
Research Chemical

BPC-157

Also known as: BPC-157, Body Protection Compound-157

A synthetic peptide fragment derived from a protein found in gastric juice, studied for its broad tissue-healing and cytoprotective effects. Popular in research for tendon, ligament, muscle, and gut repair.

Last updated

Mechanism of Action

BPC-157 is thought to upregulate angiogenesis by promoting VEGFR2 expression and activating the VEGFR2-Akt-eNOS signaling pathway, increasing blood vessel formation at injury sites. It modulates growth-hormone receptor expression in tendon fibroblasts and appears to influence the nitric oxide system. Animal studies also describe protective effects on the gut-brain axis and dopaminergic, serotonergic, and GABAergic systems.

Half-life
Approximately 4-6 hours (estimated; rapidly cleared)
Administration Routes
subcutaneous, intramuscular, oral
Research Status
Research Chemical

Reported Benefits

  • Accelerated tendon, ligament, and muscle healing in animal models
  • Cytoprotective and ulcer-healing effects on the GI tract
  • Promotes angiogenesis (new blood vessel formation) at injury sites
  • May reduce inflammation in soft tissue and joints
  • Reported neuroprotective effects in preclinical research
  • Anecdotal support for faster recovery from overuse injuries

Potential Side Effects

  • Generally well tolerated in animal studies with low toxicity
  • Possible injection-site irritation, redness, or bruising
  • Occasional reports of mild nausea or fatigue (anecdotal)
  • Long-term human safety data is lacking

Common Dosing

Research literature commonly references 200-500 mcg per administration, once or twice daily, in animal-equivalent and anecdotal human protocols. Not personal medical advice.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Known or active malignancy (theoretical concern due to angiogenic activity)
  • Pregnancy or breastfeeding (no safety data)
  • Not approved for human use; sold as research chemical only
  • Stable Gastric Pentadecapeptide BPC 157 and Wound Healing

    2021

    View
  • The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

    2011

    View
  • Pentadecapeptide BPC 157 and the central nervous system

    2022

    View
  • Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

    2025

    View

No. BPC-157 is not approved for human use and is sold strictly as a research chemical. The FDA has flagged it for restrictions in compounding. All use described here is for educational and research purposes only.

The bulk of preclinical literature focuses on soft-tissue healing (tendons, ligaments, muscle), gastrointestinal protection, and angiogenesis. Human clinical trials remain limited.

BPC-157 primarily drives angiogenesis and local tissue repair, while TB-500 (Thymosin Beta-4) acts on actin regulation and cell migration. They are frequently studied together for complementary healing pathways.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.